SEC Company Response from Enlivex Ltd. (ENLV) (CIK 0001596812) (ENLV) — Jun 19, 2019
Enlivex Ltd. (ENLV) (CIK 0001596812)
Date: June 19, 2019 · CIK: 0001596812 · Accession: 0001213900-19-011007
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-232009
Letter
VIA EDGAR Division of Corporation Finance Enlivex Therapeutics Ltd. Registration Statement on Form F-3 File No. 333-232009 Filed June 7, 2019
Dear Mr. Gabor,
In accordance with Rule 461 under the Securities Act of 1933, as amended, we hereby request acceleration of the effective date of the Registration Statement on Form F-3 (File No. 333-232009) (the “Registration Statement”) of Enlivex Therapeutics Ltd. (the “Registrant”). We respectfully request that the Registration Statement become effective as of 4:00 p.m., Eastern time, on June 21, 2019, or as soon as practicable thereafter.
The Registrant hereby authorizes Drew M. Altman of Greenberg Traurig, P.A. to orally modify or withdraw this request for acceleration.
Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Greenberg Traurig, P.A., by calling Drew M. Altman at 305-579-0589.
Thank you for your assistance in this matter.
Respectfully yours,
ENLIVEX THERAPEUTICS LTD.
Show Raw Text
CORRESP
1
filename1.htm
ENLIVEX THERAPEUTICS LTD.
14 Einstein Street
Nes Ziona
Israel 7403618
VIA EDGAR
June 19, 2019
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549-0404
Attn: Jeffrey Gabor
Re:
Enlivex Therapeutics Ltd.
Registration
Statement on Form F-3
File
No. 333-232009
Filed
June 7, 2019
Dear Mr. Gabor,
In accordance with Rule 461 under the Securities
Act of 1933, as amended, we hereby request acceleration of the effective date of the Registration Statement on Form F-3 (File No.
333-232009) (the “Registration Statement”) of Enlivex Therapeutics Ltd. (the “Registrant”). We respectfully
request that the Registration Statement become effective as of 4:00 p.m., Eastern time, on June 21, 2019, or as soon as practicable
thereafter.
The Registrant hereby authorizes Drew M. Altman
of Greenberg Traurig, P.A. to orally modify or withdraw this request for acceleration.
Once the Registration Statement has been declared
effective, please orally confirm that event with our counsel, Greenberg Traurig, P.A., by calling Drew M. Altman at 305-579-0589.
Thank you for your assistance in this matter.
Respectfully yours,
ENLIVEX THERAPEUTICS LTD.
By:
/s/ Shai Novik
Shai Novik
Chairman of the Board of Directors